Implementation of a transfusion algorithm to reduce blood product utilization in pediatric cardiac surgery

被引:41
|
作者
Whitney, Gina [1 ,2 ]
Daves, Suanne [1 ,2 ]
Hughes, Alex [1 ,2 ]
Watkins, Scott [1 ,2 ]
Woods, Marcella [3 ]
Kreger, Michael [1 ]
Marincola, Paula [4 ]
Chocron, Isaac [4 ]
Donahue, Brian [1 ,2 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Div Pediat Cardiac Anesthesiol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, VUMC Ctr Clin Improvement, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA
关键词
algorithms; blood component transfusion; cardiac; congenital; heart defects; quality improvement; red blood cell transfusion; surgery; CARDIOPULMONARY BYPASS; CONSERVATION; STRATEGIES; PROTOCOL; CHILDREN; CELL;
D O I
10.1111/pan.12126
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Aim The goal of this project is to measure the impact of standardization of transfusion practice on blood product utilization and postoperative bleeding in pediatric cardiac surgery patients. Background Transfusion is common following cardiopulmonary bypass (CPB) in children and is associated with increased mortality, infection, and duration of mechanical ventilation. Transfusion in pediatric cardiac surgery is often based on clinical judgment rather than objective data. Although objective transfusion algorithms have demonstrated efficacy for reducing transfusion in adult cardiac surgery, such algorithms have not been applied in the pediatric setting. Methods This quality improvement effort was designed to reduce blood product utilization in pediatric cardiac surgery using a blood product transfusion algorithm. We implemented an evidence-based transfusion protocol in January 2011 and monitored the impact of this algorithm on blood product utilization, chest tube output during the first 12h of intensive care unit (ICU) admission, and predischarge mortality. Results When compared with the 12months preceding implementation, blood utilization per case in the operating room odds ratio (OR) for the 11months following implementation decreased by 66% for red cells (P=0.001) and 86% for cryoprecipitate (P<0.001). Blood utilization during the first 12h of ICU did not increase during this time and actually decreased 56% for plasma (P=0.006) and 41% for red cells (P=0.031), indicating that the decrease in OR transfusion did not shift the transfusion burden to the ICU. Postoperative bleeding, as measured by chest tube output in the first 12 ICU hours, did not increase following implementation of the algorithm. Monthly surgical volume did not change significantly following implementation of the algorithm (P=0.477). In a logistic regression model for predischarge mortality among the nontransplant patients, after accounting for surgical severity and duration of CPB, use of the transfusion algorithm was associated with a 0.247 relative risk of mortality (P=0.013). Conclusions These results indicate that introduction of an objective transfusion algorithm in pediatric cardiac surgery significantly reduces perioperative blood product utilization and mortality, without increasing postoperative chest tube losses.
引用
收藏
页码:639 / 646
页数:8
相关论文
共 50 条
  • [31] IMPLEMENTATION OF A CRITERIA-BASED ALGORITHM FOR ALBUMIN UTILIZATION FOLLOWING CARDIAC SURGERY
    Shah, Ami
    Bhatt, Himani
    Di Luozzo, Gabriele
    Latouff, Omar
    Friedman, Seana
    Victory-Stewart, Marcelina
    Patel, Mukti
    Loaiza, Lina
    Shim, Ashley
    Yimen, Mekeleya
    Puskas, John
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 77 - 77
  • [32] Benefits and risks of red blood cell transfusion in pediatric patients undergoing cardiac surgery
    Guzzetta, Nina A.
    PEDIATRIC ANESTHESIA, 2011, 21 (05) : 504 - 511
  • [33] PEDIATRIC CARDIAC SURGERY: EFFECT OF A MINIATURIZED BYPASS CIRCUIT IN REDUCING HOMOLOGOUS BLOOD TRANSFUSION
    Durandy, Yves Dominique
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (06): : 1454 - 1454
  • [34] Blood transfusion in pediatric intracranial tumor surgery
    Soner, Huelya Tosun
    Oygen, Oemer
    Guvenc, Bayram
    Turkan, Rojda Tanik
    Sener, Fuat
    Soner, Serdar
    Uzundere, Osman
    Aydin, Kamuran
    Aslanoglu, Baris
    Celik, Feyzi
    BMC ANESTHESIOLOGY, 2024, 24 (01):
  • [35] Blood transfusion support in pediatric cardiovascular surgery
    Kwiatkowski, JL
    Manno, CS
    TRANSFUSION SCIENCE, 1999, 21 (01): : 63 - 72
  • [36] Impact of Blood Sampling Methods on Blood Loss and Transfusion After Pediatric Cardiac Surgery: An Observational Study
    Bin Joubah, Mohammed
    Ismail, Ahmed Abdelaziz
    Abdelmohsen, Gaser
    Alsofyani, Khouloud Abdulrhman
    Yousef, Ahmed Ali
    Jobah, Majed Tareq
    Khawaji, Adeeb
    Abdelmawla, Mohamed
    Sayed, Mohamed Hesham
    Dohain, Ahmed Mohamed
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2024, 38 (09) : 2002 - 2008
  • [37] Blood transfusion during cardiac surgery: massive transfusion coagulopathy
    A Trlaja
    D Glavaš
    C Bulat
    M Carev
    N Ipavec
    B Pauković-Sekulić
    I Bradarić
    M Deković
    N Karanović
    Journal of Cardiothoracic Surgery, 8 (Suppl 1)
  • [38] Using Quality Improvement to Optimize Blood Product Utilization in a Pediatric Cardiac Catheterization Laboratory
    Trivedi, Mira
    Sheth, Shreya
    Cooper, Felicia
    Elhoff, Justin
    Rodrigues, Miranda A.
    Stapleton, Gary
    PEDIATRIC CARDIOLOGY, 2024,
  • [39] Transfusion of non-red blood cell blood products does not reduce survival following cardiac surgery
    Bianco, Valentino
    Aranda-Michel, Edgar
    Serna-Gallegos, Derek
    Dunn-Lewis, Courtenay
    Wang, Yisi
    Thoma, Floyd
    Navid, Forozan
    Sultan, Ibrahim
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 167 (01): : 243 - 253.e5
  • [40] Utilization of technologies to reduce allogeneic blood transfusion in the United States
    Hutchinson, AB
    Fergusson, D
    Graham, ID
    Laupacis, A
    Herrin, J
    Hillyer, CD
    TRANSFUSION MEDICINE, 2001, 11 (02) : 79 - 85